Public research preview
Christopher L. Jacobs, Representative disclosure: eb nce Vaxcyte, Inc. - Common Stock (PCVX)
Disclosed a sell transaction in eb nce Vaxcyte, Inc. - Common Stock (PCVX). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 20 Jan 2023, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 39 days
Timeline
Transaction date
12 Dec 2022
Public disclosure
20 Jan 2023
Now
Tracked today
Filing delay: 39 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 10 Jun 2026
Stock path
PCVX from pre-transaction context through latest close.
Transaction
12 Dec 2022 · 44,18 USD
- Observed transaction close
- 44,18
- Observed disclosure close
- 45,1
- Observed latest close
- 46,88
- Pre-disclosure move
- +2.1%
- Post-disclosure move
- +3.9%
- Market-adjusted move
- +3.9%
Why Copy Window is Probably too late
Supporting factors
- Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 20 Jan 2023, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%